KNX News On DemandKNX News On Demand

FDA approves new Alzheimer's drug

View descriptionShare

KNX In Depth's Charles Feldman and Rob Archer discuss how many doctors will soon begin giving patients a new Alzheimer's drug that's been shown to slow down the disease. Dr. Keith Vossel is the Director of the Mary S. Easton Center for Alzheimer's Research and Care at UCLA. 

 

  • Facebook
  • Twitter
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. KNX News On Demand

    7,821 clip(s)

KNX News On Demand

KNX: On-Demand    
Social links
Follow podcast
Recent clips
Browse 11,101 clip(s)